Login to Your Account



Newron Finds New Safinamide Partner in Zambon Agreement

By Nuala Moran
Staff Writer

Friday, April 6, 2012
LONDON – Newron Pharmaceuticals SpA has found a new partner for its Phase III drug safinamide, securing a €20 million (US$26.1 million) opening payment, with milestones and royalties to come, from the Italian pharma company Zambon SpA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription